ArticleClinical pharmacology in drug development2025
Target-Mediated Modeling of Alirocumab in Adolescents and Children ≥8 to <12 Years of Age Using Phase II and III Data.
Pavel Kovalenko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.